Menopause Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc.

The Menopause Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Menopause Market:
https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

According to The Business Research Company’s Menopause Global Market Report 2024, The menopause market size has grown strongly in recent years. It will grow from $16.53 billion in 2023 to $17.74 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased life expectancy, women’s health awareness, nutritional supplements, healthcare access improvement, stress and lifestyle management, patient advocacy..

The menopause market size is expected to see strong growth in the next few years. It will grow to $22.64 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine.. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment..

The increasing physical inactivity among women is expected to propel the growth of the menopause market going forward. Physical inactivity refers to the absence or minimal physical activity that refers to all activity, including mobility during leisure time, transportation to and from places, and moving as part of a person’s job. The growing problem of physical inactivity among women during menopause contributes to a greater demand for products and services that address menopausal symptoms, health risks, and overall well-being. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, the %age of women who had no physical activity increased by 7.9% from 213,555 in 2020 to 230,493 in 2021. Therefore, the increasing physical inactivity among women is driving the menopause market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp

The menopause market covered in this report is segmented –

1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products
2) By Route of Administration: Topical, Oral, Injectables
3) By Distribution Channel: Hospital, Retail, Online Pharmacies
4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users

Major companies operating in the menopause market are focusing on developing innovative products, such as Your Meno Ease Capsules, to meet the needs of existing consumers better. Your Meno Ease Capsules is a dietary supplement that helps to relieve the symptoms of menopause in women and contains a blend of vitamins, minerals, and other nutrients that are thought to be beneficial for menopausal women. For instance, in October 2022, PharmaLinea Ltd., a Slovenia-based manufacturer of menopausal dietary supplements, launched Your Meno Ease Capsules. These revolutionary capsules are innovative with unique components and clinically validated functions ranging from general menopausal symptom alleviation to extra advantages in state of mind, mental processes, distress, cardiovascular, and bone wellness. PharmaLinea’s product is a single capsule comprising 75 mg of Qratol and 40 mg of Qsoy. It also has 1.6 mg of vitamin B6. Qsol is a soy component that has been found to reduce menopausal symptoms, while Qratol is a reservatol substance that offers several health benefits.

The menopause market report table of contents includes:

1. Executive Summary
2. Menopause Market          Characteristics
3. Menopause Market          Trends And Strategies
4. Menopause Market          – Macro Economic Scenario
5. Global   Menopause Market          Size and Growth

.

.

.

32. Global   Menopause Market          Competitive Benchmarking
33. Global   Menopause Market          Competitive Dashboard
34. Key Mergers And Acquisitions In   Menopause Market
35. Menopause Market          Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• Pfizer Inc.
• Johnson & Johnson Inc
• The Procter & Gamble Company
• Hoffmann-La Roche AG
• Merck & Co. Inc.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model